Investigating how reactive molecules affect health and developing new drugs
Tools to Study Electrophilic Stress and Develop Covalent Drugs
This study is looking at how certain reactive molecules can affect our health and lead to diseases like heart problems and cancer, with the goal of finding better treatments that could help patients feel better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10837011 on NIH RePORTER |
What this research studies
This research focuses on understanding how reactive electrophilic species, which can modify biomolecules, impact human health and contribute to diseases like atherosclerosis and cancer. The team aims to develop new methods to control these reactive molecules, allowing for precise testing of their effects and the creation of new covalent drugs. By establishing rigorous experimental techniques, the research seeks to uncover the roles of these species in disease processes and improve therapeutic strategies. Patients may benefit from new treatments that arise from this understanding.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from atherosclerotic cardiovascular disease or cancers related to oxidative stress.
Not a fit: Patients with conditions unrelated to oxidative stress or those not affected by atherosclerosis or cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative drugs that target diseases linked to reactive electrophilic species.
How similar studies have performed: While the approach to develop controlled methods for studying reactive electrophiles is innovative, similar research has shown promise in understanding their roles in disease.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Franzini, Raphael M. — University of Utah
- Study coordinator: Franzini, Raphael M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.